Pictet Asset Management (UK)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
Other funds holding ITCI
WA
BG
Pictet Asset Management (UK)'s ITCI Position: Q2 2021 in Review
Pictet Asset Management (UK) sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2021, closing a stake of 110,267 shares — an estimated $3.74M sold.
Pictet Asset Management (UK) first reported a position in ITCI in Q3 2016 and held it in 16 quarters. The position peaked at $7M in Q4 2020. 187 funds tracked by Wall St. Rank hold ITCI as of Q2 2021.
- Pictet Asset Management (UK) reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2021 after selling out during the quarter.
- Pictet Asset Management (UK) sold 110,267 Intra-Cellular Therapies Inc. shares in Q2 2021, an estimated $3.74M.
- Pictet Asset Management (UK) first reported a position in Intra-Cellular Therapies Inc. in Q3 2016 and held it in 16 quarters.
- Pictet Asset Management (UK)'s Intra-Cellular Therapies Inc. position peaked at $7M in Q4 2020.
- 187 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2021.
Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.